InsiderSignal.AI

InsiderSignal.ai

ABSI - Absci Corp

Insider Purchase by Pangalos Menelas N (Dir)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

5 months ago, Pangalos Menelas N, serving as Dir at Absci Corp (ABSI), purchased 95,785 shares at $2.66 per share, for a total transaction value of $254,788.00. Following this transaction, Pangalos Menelas N now holds 113,960 shares of ABSI.

This purchase represents a 527.00% increase in Pangalos Menelas N's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, September 22, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, September 24, 2025, 2 days after the trade was made.

Absci Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Pangalos Menelas N

Dir

Prof. Sir Menelas (Mene) Pangalos, Ph.D., age 58, is an independent director (Class II) at Absci Corporation (ABSI) since January 1, 2024, with his term expiring at the 2026 annual meeting.[[1]](https://fintool.com/app/research/companies/ABSI/people/menelas-pangalos)[[6]](https://uk.marketscreener.com/insider/MENELAS-NICOLAS-PANGALOS-A15HDC/) He holds a Ph.D. in Neurochemistry (or Neuropharmacology) and a B.S. in Biochemistry (or Biochemistry and Molecular Biology) from the University of London institutions including University College London and Imperial College.[[1]](https://fintool.com/app/research/companies/ABSI/people/menelas-pangalos)[[2]](https://www.biogen.com/company/leadership/sir-menelas-pangalos.html) Knighted in 2019, he is a Fellow of the Royal Society, Academy of Medical Sciences, Royal Society of Biology, and Clare Hall, Cambridge, and serves as Visiting Professor of Neuroscience at King’s College London since 2005.[[1]](https://fintool.com/app/research/companies/ABSI/people/menelas-pangalos)[[2]](https://www.biogen.com/company/leadership/sir-menelas-pangalos.html) Pangalos brings over three decades of senior R&D leadership in pharmaceuticals, most notably as Executive Vice President of Biopharmaceuticals R&D at AstraZeneca from 2019 to 2024, where he oversaw global R&D operations across 40 sites with a $4 billion budget, transforming productivity with success rates four times the industry average and accelerating drugs like osimertinib to market in 2.5 years.[[1]](https://fintool.com/app/research/companies/ABSI/people/menelas-pangalos)[[2]](https://www.biogen.com/company/leadership/sir-menelas-pangalos.html)[[3]](https://www.isomorphiclabs.com/people/sir-menelas-pangalos-phd)[[4]](https://en.wikipedia.org/wiki/Mene_Pangalos)[[5]](https://docs.house.gov/meetings/IF/IF02/20200721/110926/HHRG-116-IF02-Bio-PangalosM-20200721-U1.pdf) Previously, he held EVP roles at AstraZeneca since 2010, and senior positions at Pfizer (SVP and CSO Neuroscience, 2009-2010), Wyeth, and GlaxoSmithKline.[[1]](https://fintool.com/app/research/companies/ABSI/people/menelas-pangalos)[[2]](https://www.biogen.com/company/leadership/sir-menelas-pangalos.html)[[4]](https://en.wikipedia.org/wiki/Mene_Pangalos)[[5]](https://docs.house.gov/meetings/IF/IF02/20200721/110926/HHRG-116-IF02-Bio-PangalosM-20200721-U1.pdf) He currently serves on the boards of Biogen Inc. (since January 2025, Compensation Committee) and others, post-retirement from AstraZeneca.[[1]](https://fintool.com/app/research/companies/ABSI/people/menelas-pangalos)[[2]](https://www.biogen.com/company/leadership/sir-menelas-pangalos.html)[[6]](https://uk.marketscreener.com/insider/MENELAS-NICOLAS-PANGALOS-A15HDC/)

View full insider profile →

Trade Price

$2.66

Quantity

95,785

Total Value

$254,788.00

Shares Owned

113,960

Trade Date

Monday, September 22, 2025

153 days ago

SEC Filing Date

Wednesday, September 24, 2025

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Absci Corp

Company Overview

No company information available
View news mentioning ABSI

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/476520

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime